NO20055607L - Antilosemiddel solidifiseringsprosess - Google Patents
Antilosemiddel solidifiseringsprosessInfo
- Publication number
- NO20055607L NO20055607L NO20055607A NO20055607A NO20055607L NO 20055607 L NO20055607 L NO 20055607L NO 20055607 A NO20055607 A NO 20055607A NO 20055607 A NO20055607 A NO 20055607A NO 20055607 L NO20055607 L NO 20055607L
- Authority
- NO
- Norway
- Prior art keywords
- antelope
- solidification process
- organic
- inorganic compound
- solvent solidification
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D9/00—Crystallisation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D9/00—Crystallisation
- B01D9/0063—Control or regulation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D9/00—Crystallisation
- B01D9/005—Selection of auxiliary, e.g. for control of crystallisation nuclei, of crystal growth, of adherence to walls; Arrangements for introduction thereof
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D9/00—Crystallisation
- B01D9/005—Selection of auxiliary, e.g. for control of crystallisation nuclei, of crystal growth, of adherence to walls; Arrangements for introduction thereof
- B01D9/0054—Use of anti-solvent
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01D—COMPOUNDS OF ALKALI METALS, i.e. LITHIUM, SODIUM, POTASSIUM, RUBIDIUM, CAESIUM, OR FRANCIUM
- C01D3/00—Halides of sodium, potassium or alkali metals in general
- C01D3/22—Preparation in the form of granules, pieces, or other shaped products
- C01D3/24—Influencing the crystallisation process
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
- C07J7/0045—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Crystallography & Structural Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Materials Engineering (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Physical Or Chemical Processes And Apparatus (AREA)
- Steroid Compounds (AREA)
- Glanulating (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Colloid Chemistry (AREA)
Abstract
Forehggende oppfirmelse omhandler en antiløsemiddel sohdifiseringsprosess hvori et flytende medium som omfatter minst én organisk eller uorganisk forbindelse som skal solidifiseres blfr tvunget gjermom en membran irm i ett eller flere antiløsemidler, eller hvori ett eller flere antiløsemidler blir tvunget gjermom en membran irm i et flytende medium som omfatter minst én organisk eller uorganisk forbindelse som skal solidifiseres, hvilket gir en sammensetning som omfatter faste partikler som omfatter nevnte organiske og/eller uorganiske forbindelse(r).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US46676103P | 2003-04-29 | 2003-04-29 | |
PCT/EP2004/004506 WO2004096405A1 (en) | 2003-04-29 | 2004-04-28 | Antisolvent solidification process |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20055607D0 NO20055607D0 (no) | 2005-11-28 |
NO20055607L true NO20055607L (no) | 2005-11-28 |
Family
ID=33418418
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20055607A NO20055607L (no) | 2003-04-29 | 2005-11-28 | Antilosemiddel solidifiseringsprosess |
Country Status (23)
Country | Link |
---|---|
US (4) | US20060182808A1 (no) |
EP (1) | EP1620193B1 (no) |
JP (1) | JP5207432B2 (no) |
KR (1) | KR20060006949A (no) |
CN (1) | CN100434133C (no) |
AR (1) | AR044140A1 (no) |
AT (1) | ATE406946T1 (no) |
AU (1) | AU2004234057A1 (no) |
BR (1) | BRPI0409860A (no) |
CA (1) | CA2523883C (no) |
CL (1) | CL2004000912A1 (no) |
DE (1) | DE602004016311D1 (no) |
ES (1) | ES2312996T3 (no) |
HK (1) | HK1088268A1 (no) |
IL (1) | IL171613A (no) |
MX (1) | MXPA05011626A (no) |
MY (1) | MY141189A (no) |
NO (1) | NO20055607L (no) |
NZ (1) | NZ543772A (no) |
RU (1) | RU2339364C2 (no) |
TW (1) | TW200500095A (no) |
WO (1) | WO2004096405A1 (no) |
ZA (1) | ZA200509597B (no) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103462943A (zh) * | 2005-07-15 | 2013-12-25 | Map药物公司 | 在离散的吸入粒子中结合的多种活性药物成分及其制剂 |
EP1904219A4 (en) * | 2005-07-15 | 2011-07-27 | Map Pharmaceuticals Inc | METHOD FOR FORMING PARTICLES |
US7942990B2 (en) | 2006-12-18 | 2011-05-17 | Daicel Chemical Industries, Ltd. | Hybrid inflator |
ES2381892T3 (es) * | 2007-01-22 | 2012-06-01 | Cargill, Incorporated | Procedimiento para producir composiciones de rebaudiósido A purificado que utiliza la cristalización disolvente/antidisolvente |
GB0705159D0 (en) * | 2007-03-19 | 2007-04-25 | Prosonix Ltd | Process for making crystals |
FI120527B (fi) * | 2007-06-18 | 2009-11-30 | Crisolteq Oy | Talteenottomenetelmä |
GB0711680D0 (en) * | 2007-06-18 | 2007-07-25 | Prosonix Ltd | Process |
US20100291221A1 (en) * | 2009-05-15 | 2010-11-18 | Robert Owen Cook | Method of administering dose-sparing amounts of formoterol fumarate-budesonide combination particles by inhalation |
TWI466709B (zh) * | 2011-07-20 | 2015-01-01 | Nat Univ Chung Hsing | From the original berry Wolfberry a liquid - liquid freezing method for separation of high purity theaflavins palmitate Maize |
US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
MX365818B (es) | 2011-11-23 | 2019-05-30 | Therapeuticsmd Inc | Formulaciones y terapias de reemplazo hormonal de combinacion naturales. |
US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US9452930B2 (en) * | 2013-11-04 | 2016-09-27 | New Jersey Institute Of Technology | System and method for continuous polymer coating of particles |
US10206932B2 (en) | 2014-05-22 | 2019-02-19 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
PT108368B (pt) | 2015-03-31 | 2018-11-05 | Hovione Farm S A | Produção contínua de partículas |
US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
CN106853295A (zh) * | 2015-12-09 | 2017-06-16 | 北大方正集团有限公司 | 一种基于膜分散的结晶方法 |
AU2017239645A1 (en) | 2016-04-01 | 2018-10-18 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical composition |
WO2017173044A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd Inc. | Steroid hormone compositions in medium chain oils |
US10881123B2 (en) * | 2017-10-27 | 2021-01-05 | Frito-Lay North America, Inc. | Crystal morphology for sodium reduction |
CN112261974B (zh) * | 2018-06-14 | 2022-10-11 | 日挥株式会社 | 晶析装置和晶析方法 |
WO2020135352A1 (zh) * | 2018-12-28 | 2020-07-02 | 四川科伦药物研究院有限公司 | 制备黄体酮颗粒物的方法、所得黄体酮颗粒物及其注射剂 |
CN111234431A (zh) * | 2020-03-31 | 2020-06-05 | 宁夏颐星新材料科技有限公司 | 一种消泡型聚乙烯醇粉末的生产工艺 |
GB202004824D0 (en) * | 2020-04-01 | 2020-05-13 | Naturbeads Ltd | Biopolymer particle preparation |
GB202011836D0 (en) | 2020-07-30 | 2020-09-16 | Micropore Tech Limited | Crystallisation methods |
CN115777906A (zh) * | 2021-09-10 | 2023-03-14 | 吉林大学 | 氯化钠纳微米粒子及其制备方法和应用 |
CN117942426B (zh) * | 2024-03-22 | 2024-05-31 | 四川大学 | 一种具有取向孔道结构的多级多孔材料及其制备方法和应用 |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2716453B1 (fr) * | 1994-02-22 | 1996-03-29 | Rhone Poulenc Agrochimie | Procédé de sulfinylation de composés hétérocycliques. |
US4089843A (en) * | 1976-09-20 | 1978-05-16 | The Upjohn Company | Precipitating polymers in powder form |
US4826689A (en) * | 1984-05-21 | 1989-05-02 | University Of Rochester | Method for making uniformly sized particles from water-insoluble organic compounds |
US4783484A (en) * | 1984-10-05 | 1988-11-08 | University Of Rochester | Particulate composition and use thereof as antimicrobial agent |
JPH0672528B2 (ja) * | 1985-07-16 | 1994-09-14 | 三信工業株式会社 | 船舶のエンジン |
US5269926A (en) * | 1991-09-09 | 1993-12-14 | Wisconsin Alumni Research Foundation | Supported microporous ceramic membranes |
FR2658498B1 (fr) * | 1990-02-19 | 1992-05-15 | Atochem | Particules de chlorure de magnesium a structure tronc conique, composante catalytique supportee sur ces particules, polyolefines obtenues a partir de cette composante catalytique, procedes de fabrication de ces produits. |
JP2555475B2 (ja) * | 1990-10-16 | 1996-11-20 | 工業技術院長 | 無機質微小球体の製造方法 |
JP2816597B2 (ja) * | 1990-11-28 | 1998-10-27 | 富士写真フイルム株式会社 | 溶液の均一混合装置および弾性体多孔膜 |
IE71202B1 (en) * | 1990-12-17 | 1997-02-12 | Akzo Nv | Progestagen-only contraceptive |
WO1993000156A1 (en) * | 1991-06-29 | 1993-01-07 | Miyazaki-Ken | Monodisperse single and double emulsions and production thereof |
CA2124821C (en) * | 1991-12-18 | 2003-10-07 | Isaac Ghebre-Sellassie | Novel solid pharmaceutical dispersions |
DK95093D0 (da) * | 1993-08-20 | 1993-08-20 | Novo Nordisk As | Farmaceutisk formulering indeholdende et hormon |
JPH09508055A (ja) * | 1993-11-08 | 1997-08-19 | ザ、ジレット、カンパニー | 超臨界流体を用いる粒子の形成法、これによって形成されるエーロゲル粒子、およびエーロゲル粒子を含む制汗剤 |
JP3492787B2 (ja) * | 1994-04-15 | 2004-02-03 | 信越化学工業株式会社 | 固形製剤のコーティング用水性エマルジョンの濃縮方法 |
US6387399B1 (en) * | 1994-12-02 | 2002-05-14 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Microencapsulated bioactive agents and method of making |
SE9501384D0 (sv) * | 1995-04-13 | 1995-04-13 | Astra Ab | Process for the preparation of respirable particles |
US5876480A (en) * | 1996-02-20 | 1999-03-02 | The United States Of America As Represented By The Secretary Of The Navy | Synthesis of unagglomerated metal nano-particles at membrane interfaces |
GB9610955D0 (en) * | 1996-05-24 | 1996-07-31 | Hercules Inc | Sizing composition |
IL123984A (en) * | 1997-04-22 | 2004-09-27 | Akzo Nobel Nv | Pharmacological dosage units containing tibolone and carrier pharmacy are acceptable |
US5879715A (en) * | 1997-09-02 | 1999-03-09 | Ceramem Corporation | Process and system for production of inorganic nanoparticles |
CA2326349A1 (en) * | 1998-04-09 | 1999-10-21 | F. Hoffmann-La Roche Ag | Process for the manufacture of (sub)micron sized particles by dissolving in compressed gas and surfactants |
SE9801287D0 (sv) * | 1998-04-14 | 1998-04-14 | Astra Ab | Incorporation of active substances in carrier matrixes |
US6113795A (en) * | 1998-11-17 | 2000-09-05 | The University Of Kansas | Process and apparatus for size selective separation of micro- and nano-particles |
US7374779B2 (en) * | 1999-02-26 | 2008-05-20 | Lipocine, Inc. | Pharmaceutical formulations and systems for improved absorption and multistage release of active agents |
IN191236B (no) * | 1999-05-25 | 2003-10-11 | Ranbaxy Lab Ltd | |
US6780507B2 (en) * | 2000-02-09 | 2004-08-24 | Analytical Research Systems, Inc. | Hydrocapsules and method of preparation thereof |
US6623761B2 (en) * | 2000-12-22 | 2003-09-23 | Hassan Emadeldin M. | Method of making nanoparticles of substantially water insoluble materials |
GB0102075D0 (en) * | 2001-01-26 | 2001-03-14 | Astrazeneca Ab | Process |
US20030049323A1 (en) * | 2001-08-29 | 2003-03-13 | Hitt James E. | Process to precipitate drug particles |
KR20050035146A (ko) * | 2001-10-10 | 2005-04-15 | 베링거 인겔하임 파마슈티칼즈, 인코포레이티드 | 가압 기체성 유체를 사용하는 분말 가공 |
US6890592B2 (en) * | 2002-03-13 | 2005-05-10 | Appleton Papers Inc. | Uniform microcapsules |
US6966990B2 (en) * | 2002-10-11 | 2005-11-22 | Ferro Corporation | Composite particles and method for preparing |
-
2004
- 2004-04-28 WO PCT/EP2004/004506 patent/WO2004096405A1/en active IP Right Grant
- 2004-04-28 KR KR1020057020462A patent/KR20060006949A/ko not_active Application Discontinuation
- 2004-04-28 DE DE602004016311T patent/DE602004016311D1/de not_active Expired - Lifetime
- 2004-04-28 NZ NZ543772A patent/NZ543772A/en unknown
- 2004-04-28 EP EP04729890A patent/EP1620193B1/en not_active Expired - Lifetime
- 2004-04-28 BR BRPI0409860-9A patent/BRPI0409860A/pt not_active IP Right Cessation
- 2004-04-28 MX MXPA05011626A patent/MXPA05011626A/es active IP Right Grant
- 2004-04-28 US US10/553,211 patent/US20060182808A1/en not_active Abandoned
- 2004-04-28 CA CA2523883A patent/CA2523883C/en not_active Expired - Fee Related
- 2004-04-28 ES ES04729890T patent/ES2312996T3/es not_active Expired - Lifetime
- 2004-04-28 CN CNB2004800113339A patent/CN100434133C/zh not_active Expired - Fee Related
- 2004-04-28 JP JP2006505309A patent/JP5207432B2/ja not_active Expired - Fee Related
- 2004-04-28 AT AT04729890T patent/ATE406946T1/de not_active IP Right Cessation
- 2004-04-28 RU RU2005136983/15A patent/RU2339364C2/ru active
- 2004-04-28 AU AU2004234057A patent/AU2004234057A1/en not_active Abandoned
- 2004-04-29 CL CL200400912A patent/CL2004000912A1/es unknown
- 2004-04-29 MY MYPI20041619A patent/MY141189A/en unknown
- 2004-04-29 TW TW093112056A patent/TW200500095A/zh unknown
- 2004-04-29 AR ARP040101476A patent/AR044140A1/es active IP Right Grant
-
2005
- 2005-10-27 IL IL171613A patent/IL171613A/en not_active IP Right Cessation
- 2005-11-28 NO NO20055607A patent/NO20055607L/no not_active Application Discontinuation
- 2005-11-28 ZA ZA200509597A patent/ZA200509597B/en unknown
-
2006
- 2006-08-10 HK HK06108874.8A patent/HK1088268A1/xx not_active IP Right Cessation
-
2011
- 2011-05-03 US US13/099,926 patent/US20110268806A1/en not_active Abandoned
-
2012
- 2012-05-25 US US13/481,088 patent/US20120232296A1/en not_active Abandoned
-
2013
- 2013-01-09 US US13/737,061 patent/US20130131029A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2523883C (en) | 2012-01-03 |
EP1620193A1 (en) | 2006-02-01 |
ZA200509597B (en) | 2006-12-27 |
BRPI0409860A (pt) | 2006-05-16 |
WO2004096405A1 (en) | 2004-11-11 |
MY141189A (en) | 2010-03-31 |
CL2004000912A1 (es) | 2005-02-04 |
AR044140A1 (es) | 2005-08-24 |
US20110268806A1 (en) | 2011-11-03 |
JP2006524565A (ja) | 2006-11-02 |
MXPA05011626A (es) | 2006-01-23 |
US20120232296A1 (en) | 2012-09-13 |
CN100434133C (zh) | 2008-11-19 |
AU2004234057A1 (en) | 2004-11-11 |
RU2339364C2 (ru) | 2008-11-27 |
HK1088268A1 (en) | 2006-11-03 |
DE602004016311D1 (de) | 2008-10-16 |
EP1620193B1 (en) | 2008-09-03 |
ATE406946T1 (de) | 2008-09-15 |
CA2523883A1 (en) | 2004-11-11 |
IL171613A (en) | 2010-02-17 |
TW200500095A (en) | 2005-01-01 |
ES2312996T3 (es) | 2009-03-01 |
NZ543772A (en) | 2009-05-31 |
JP5207432B2 (ja) | 2013-06-12 |
US20130131029A1 (en) | 2013-05-23 |
NO20055607D0 (no) | 2005-11-28 |
RU2005136983A (ru) | 2006-03-20 |
KR20060006949A (ko) | 2006-01-20 |
CN1780670A (zh) | 2006-05-31 |
US20060182808A1 (en) | 2006-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20055607L (no) | Antilosemiddel solidifiseringsprosess | |
CY1111817T1 (el) | Απομακρυνση του διαλυτη με μια διαδικασια προσθιας οσμωσης | |
NO20042321L (no) | Partikkelfjerningssystem | |
EA200501263A1 (ru) | Удаление загрязнителей из природного газа с помощью охлаждения | |
SE0402322D0 (sv) | Method of preparing a chromatography matrix | |
DK1652909T3 (da) | Korrosionsbeskyttelsesmiddel til funktionelle væsker, vandblandbart koncentrat og anvendelse heraf | |
SMAP200900097A (it) | Sistema e metodo per rimuovere biossido di carbonio da un'atmosfera e termostato globale che utilizza il medesimo | |
HK1082430A1 (en) | Method for the preparation of molecular complexes | |
AR052827A1 (es) | Composicion veterinaria inyectable | |
BRPI0612577A2 (pt) | dispositivo, aparelho, sistema e método para misturar um meio líquido | |
ATE365801T1 (de) | Modulierung durch il-tif/interleukin-21 | |
FI20031642A0 (fi) | Oksapuu-uutteiden uusi käyttö | |
BR0307518A (pt) | Composição farmacêutica | |
TW200714688A (en) | Method for regenerating fluorescent material and fluorescent lamp | |
CY1115474T1 (el) | Χρωματογραφικη μεθοδος | |
EA201991962A1 (ru) | Агент для извлечения металлов, агент для извлечения соединений металлов и способ извлечения металлов или соединений металлов | |
EA200501698A1 (ru) | Противовспенивающие композиции | |
ATE477533T1 (de) | Polymorphismus zur laufzeit | |
DK1658494T3 (da) | Fremgangsmåde til en in vitro titrering af en NCTA og anvendelse deraf i en fremgangsmåde til evalueringen og/eller monitorering af en biologisk produktproduktionsfremgangsmåde | |
JP2015173986A5 (no) | ||
RU99127483A (ru) | Способ бальзамирования анатомических препаратов силоксановыми композициями | |
SE0702711L (sv) | Ny kemisk substans lämplig för användning som mjukgörare i sprängämnes- och drivmedelsblandningar | |
TH68562A (th) | กรรมวิธีการทำให้เป็นของแข็งแบบต่อต้านตัวทำละลาย | |
McMath | Cutting the cost of tunnel vision | |
RU2004117239A (ru) | Способ торможения вертикальных гидроагрегатов |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |